Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

Differential Effect of Upfront Intensification Treatment in Genetically Defined Myeloma Risk Groups - a Combined Analysis of ISS, Del17p and SKY92 Scores in the EMN-02/HOVON-95 MM Trial

Davine Hofste op Bruinink, MD MSc, Mark van Duin, PhD, Meral Beksac, MD, Christoph Driessen, MD, Heinz Ludwig, MD, Michael Vermeulen, BSc, Rowan Kuiper, MSc, Martin H van Vliet, PhD, Bronno van der Holt, PhD, Roman Hajek, MD PhD, Hans Erik Johnsen, MD Professor, Meletios A Dimopoulos, MD, Antonio Palumbo, MD, Michele Cavo, MD, Pieter Sonneveld, MD PhD

Blood (2018) 132 (Supplement 1): 3186.

https://doi.org/10.1182/blood-2018-99-119873

Published: 2018

Journal Articles

Beneficial Effect of Microrna-155 in Vincristine Response and Clinical Outcome in Especially GCB Diffuse Large B-Cell Lymphoma

Hanne Due, MSc, Anna Amanda Schönherz, PhD, Laura Barett Ryø, MSc, Anne Stidsholt Roug, MD Ass. Prof, Hans Erik Johnsen, MD Professor, Martin Bøgsted, Professor, Jacob Giehm Mikkelsen, Prof, Karen Dybkær, Professor

Blood (2017) 130 (Supplement 1): 2838.

https://doi.org/10.1182/blood.V130.Suppl_1.2838.2838

Published: 2017

Journal Articles

Lymphoma Patients Treated without Anthracyclines Have Negligible Risk of Cardiotoxicity: A Nationwide Cohort Study

Joachim Baech, Steen Moeller Hansen, Peter Enemark Lund, Christian Torp-Pedersen, Peter Soegaard, Peter de Nully Brown, MD PhD, Henrik Frederiksen, Judit Mészáros Jørgensen, Joern Starklint, Pär Josefsson, MD PhD, Christian Bjørn Poulsen, Hans Erik Johnsen, MD Professor, Tarec Christoffer El-Galaly, MD PhD

Blood (2017) 130 (Supplement 1): 2843.

https://doi.org/10.1182/blood.V130.Suppl_1.2843.2843

Published: 2017

Journal Articles

Acute Myeloid Leukemia Classification System That Associates Normal Myeloid-Cell Subset Gene Signatures with Prognosis

Anna Amanda Schönherz, PhD, Julie Støve Bødker, PhD, Alexander Schmitz, Rasmus Froberg Brøndum, Senior Bioinformatician, Lasse Hjort Jakobsen, MSc, Marianne Tang Severinsen, MD PhD, Tarec Christoffer El-Galaly, MD PhD, Karen Dybkær, Professor, Martin Bøgsted, Professor, Hans Erik Johnsen, MD Professor

Blood (2017) 130 (Supplement 1): 2689.

https://doi.org/10.1182/blood.V130.Suppl_1.2689.2689

Published: 2017

Journal Articles

Gender-Based Differences in Efficacy of Immuno-Chemotherapy for Diffuse Large B-Cell Lymphoma Revisited: A Danish Population-Based Study

Mette Dahl Bendtsen, MSc, Lasse Hjort Jakobsen, MSc, Judit Mészáros Jørgensen, Hans Erik Johnsen, MD Professor, Pär Lars Josefsson, MD, Christian Bjørn Poulsen, Jørn Starklint, MD, Gabriela Felicia Stein, MD, Per Trøllund Pedersen, MD, Jacob Haaber Christensen, MD PhD, Martin Bøgsted, Professor, Peter de Nully Brown, MD PhD, Tarec Christoffer El-Galaly, MD PhD

Blood (2017) 130 (Supplement 1): 1561.

https://doi.org/10.1182/blood.V130.Suppl_1.1561.1561

Published: 2017

Journal Articles

Autologous Stem Cell Transplantation Versus Bortezomib-Melphalan-Prednisone for Newly Diagnosed Multiple Myeloma: Second Interim Analysis of the Phase 3 EMN02/HO95 Study

Blood (2017) 130 (Supplement 1): 397.

https://doi.org/10.1182/blood.V130.Suppl_1.397.397

Published: 2017

Journal Articles

B-Cell Differentiation Dependent Classification of Diffuse Large B-Cell Lymphoma By the Nanostring Technology

Thomas Yssing Michaelsen, BS, Rasmus Froberg Brøndum, Senior Bioinformatician, Julia Richter, PhD, Wolfram Klapper, MD, Mads Albertsen, Associate Professor, Hans Erik Johnsen, MD Professor, Karen Dybkær, Professor, Tarec Christoffer El-Galaly, MD PhD, Martin Bøgsted, Professor

Blood (2017) 130 (Supplement 1): 3995.

https://doi.org/10.1182/blood.V130.Suppl_1.3995.3995

Published: 2017

Journal Articles

Bortezomib-Based Therapy Overcomes the Adverse Impact of Renal Impairment in Transplant Eligible Patients: An Analysis of the Prospective Randomized EMN02/HO95 Study

Blood (2017) 130 (Supplement 1): 4545.

https://doi.org/10.1182/blood.V130.Suppl_1.4545.4545

Published: 2017

Journal Articles

Routine Follow-up Visits for Chronic Lymphocytic Leukemia Managed Initially By Watch and Wait Rarely Lead to Interventions: A North Denmark Population-Based Study

Caroline Holm Nørgaard, BSc, Nikoline Buus Søgaard, BSc, Jorne Lionel Biccler, MSc, Laura Pilgaard, BSc, Mathias Holmsgaard Eskesen, BSc, Thordis Helga Kjartansdóttir, BSc, Hans Erik Johnsen, MD Professor, Martin Bøgsted, Professor, Mette Dahl Bendtsen, MSc, Tarec Christoffer El-Galaly, MD PhD

Blood (2017) 130 (Supplement 1): 5330.

https://doi.org/10.1182/blood.V130.Suppl_1.5330.5330

Published: 2017

Journal Articles

Intensification Therapy with Bortezomib-Melphalan-Prednisone Versus Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma: An Intergroup, Multicenter, Phase III Study of the European Myeloma Network (EMN02/HO95 MM Trial)

Blood (2016) 128 (22): 673.

https://doi.org/10.1182/blood.V128.22.673.673

Published: 2016

Journal Articles

Consolidation Followed By Maintenance Therapy Versus Maintenance Alone in Newly Diagnosed, Transplant Eligible Patients with Multiple Myeloma (MM): A Randomized Phase 3 Study of the European Myeloma Network (EMN02/HO95 MM Trial)

Blood (2016) 128 (22): 242.

https://doi.org/10.1182/blood.V128.22.242.242

Published: 2016

Journal Articles

A Randomized Phase III Trial of Melphalan and Dexamethasone (MDex) Versus Bortezomib, Melphalan and Dexamethasone (BMDex) for Untreated Patients with AL Amyloidosis

Blood (2016) 128 (22): 646.

https://doi.org/10.1182/blood.V128.22.646.646

Published: 2016

Journal Articles

Normal B-Cell Gene Expression Signatures Classifies Chronic Lymphocytic Leukemia into Distinct Subtypes - Indication of Plasticity

Caroline Holm Nørgaard, BSc.MD, Lasse Hjort Jakobsen, MS, Andrew J. Gentles, PhD, Karen Dybkaer, Professor MSO, Julie Støve Bødker, PhD, Alexander Schmitz, PhD, Preben Johansen, MD, Karsten Spiekermann, MD, Tobias Herold, MD, Tarec Christoffer El-Galaly, MD, Hans Erik Johnsen, MDDMSc, Martin Bøgsted, Professor MSO

Blood (2016) 128 (22): 2017.

https://doi.org/10.1182/blood.V128.22.2017.2017

Published: 2016

Journal Articles

Flowcytometric Minimal Residual Disease Assessment in the EMN-02/HOVON-95 MM Trial: Used Methods and a Comparison of Their Sensitivity

Davine Hofste op Bruinink, MD MSc, Stefania Oliva, MD, Lucie Rihova, PhD, Bronno van der Holt, PhD, Milena Gilestro, BSc, Jeroen G. te Marvelde, BSc, Pavla Vsianska, MSc, Alexander Schmitz, PhD, Helle Høholt, BSc, Hans Erik Johnsen, MDDMSc, Mario Boccadoro, MD, Roman Hajek, MD, Pieter Sonneveld, MD PhD, Antonio Palumbo, MD, Paola Omedè, PhD, Vincent H.J. van der Velden, PhD

Blood (2016) 128 (22): 2072.

https://doi.org/10.1182/blood.V128.22.2072.2072

Published: 2016

Journal Articles

Reproducible Diagnosis of Chronic Lymphocytic Leukemia (CLL) By Flow Cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation Project

Blood (2015) 126 (23): 4146.

https://doi.org/10.1182/blood.V126.23.4146.4146

Published: 2015

Journal Articles

High Expression of CXCR4 Impairs Anti-CD20 Monoclonal Antibody (Rituximab)-Dependent Cytotoxicity in Diffuse Large B-Cell Lymphoma

Linn Rønlev Reinholdt, PhDStudent, Maria Bach Laursen, PhD, Steffen Falgreen, PhD, Alexander Schmitz, Dr. rer. nat., Julie Støve Bødker, PhD, Martin Boegsted, Professor MSO, Hans Erik Johnsen, Professor, MD, Karen Dybkaer, Professor MSO

Blood (2015) 126 (23): 1455.

https://doi.org/10.1182/blood.V126.23.1455.1455

Published: 2015

Journal Articles

Subtyping of B-Cell Malignancies By B-Cell Subset Associated Gene Signatures (BAGS), Generated from Human Primary and Secondary Lymphoid Organs.

Julie Støve Bødker, PhD, Alexander Schmitz, Dr. rer. nat., Anders Ellern Bilgrau, PhDstudent, Andreas Rasmussen, M.Sc., Lasse Hjort Jakobsen, PhDstudent, Tarec Christoffer El-Galaly, MD, Hans Erik Johnsen, Karen Dybkær, Professor, Martin Bøgsted, Professor

Blood (2015) 126 (23): 5347.

https://doi.org/10.1182/blood.V126.23.5347.5347

Published: 2015

Journal Articles

The Absolute Number of Extranodal Sites Detected By PET-CT Is a Powerful Predictor of Secondary Central Nervous System Involvement in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP

Blood (2015) 126 (23): 3905.

https://doi.org/10.1182/blood.V126.23.3905.3905

Published: 2015

Journal Articles

A Diffuse Large B-Cell Lymphoma Classification System That Associates Normal B-Cell Subset Phenotypes with Prognosis

Blood (2014) 124 (21): 2973.

https://doi.org/10.1182/blood.V124.21.2973.2973

Published: 2014

Journal Articles

A Multiple Myeloma Classification System That Associates Normal Bone Marrow B-Cell Subset Phenotypes with Disease Stage and Prognosis

Hans Erik Johnsen, Julie Støve Bødker, MSc, PhD, Alexander Schmitz, Malene Krag Kjeldsen, Kim Steve Bergkvist, Steffen Falgreen, MSc, PhD, Anders Ellern Bilgrau, Tarec Christoffer El-Galaly, Karen Dybkær, Martin Bøgsted

Blood (2014) 124 (21): 3352.

https://doi.org/10.1182/blood.V124.21.3352.3352

Published: 2014

NARROW

Differential Effect of Upfront Intensification Treatment in Genetically Defined Myeloma Risk Groups - a Combined Analysis of ISS, Del17p and SKY92 Scores in the EMN-02/HOVON-95 MM Trial

Beneficial Effect of Microrna-155 in Vincristine Response and Clinical Outcome in Especially GCB Diffuse Large B-Cell Lymphoma

Lymphoma Patients Treated without Anthracyclines Have Negligible Risk of Cardiotoxicity: A Nationwide Cohort Study

Acute Myeloid Leukemia Classification System That Associates Normal Myeloid-Cell Subset Gene Signatures with Prognosis

Gender-Based Differences in Efficacy of Immuno-Chemotherapy for Diffuse Large B-Cell Lymphoma Revisited: A Danish Population-Based Study

Autologous Stem Cell Transplantation Versus Bortezomib-Melphalan-Prednisone for Newly Diagnosed Multiple Myeloma: Second Interim Analysis of the Phase 3 EMN02/HO95 Study

B-Cell Differentiation Dependent Classification of Diffuse Large B-Cell Lymphoma By the Nanostring Technology

Bortezomib-Based Therapy Overcomes the Adverse Impact of Renal Impairment in Transplant Eligible Patients: An Analysis of the Prospective Randomized EMN02/HO95 Study

Routine Follow-up Visits for Chronic Lymphocytic Leukemia Managed Initially By Watch and Wait Rarely Lead to Interventions: A North Denmark Population-Based Study

Intensification Therapy with Bortezomib-Melphalan-Prednisone Versus Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma: An Intergroup, Multicenter, Phase III Study of the European Myeloma Network (EMN02/HO95 MM Trial)

Consolidation Followed By Maintenance Therapy Versus Maintenance Alone in Newly Diagnosed, Transplant Eligible Patients with Multiple Myeloma (MM): A Randomized Phase 3 Study of the European Myeloma Network (EMN02/HO95 MM Trial)

A Randomized Phase III Trial of Melphalan and Dexamethasone (MDex) Versus Bortezomib, Melphalan and Dexamethasone (BMDex) for Untreated Patients with AL Amyloidosis

Normal B-Cell Gene Expression Signatures Classifies Chronic Lymphocytic Leukemia into Distinct Subtypes - Indication of Plasticity

Flowcytometric Minimal Residual Disease Assessment in the EMN-02/HOVON-95 MM Trial: Used Methods and a Comparison of Their Sensitivity

Reproducible Diagnosis of Chronic Lymphocytic Leukemia (CLL) By Flow Cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation Project

High Expression of CXCR4 Impairs Anti-CD20 Monoclonal Antibody (Rituximab)-Dependent Cytotoxicity in Diffuse Large B-Cell Lymphoma

Subtyping of B-Cell Malignancies By B-Cell Subset Associated Gene Signatures (BAGS), Generated from Human Primary and Secondary Lymphoid Organs.

The Absolute Number of Extranodal Sites Detected By PET-CT Is a Powerful Predictor of Secondary Central Nervous System Involvement in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP

A Diffuse Large B-Cell Lymphoma Classification System That Associates Normal B-Cell Subset Phenotypes with Prognosis

A Multiple Myeloma Classification System That Associates Normal Bone Marrow B-Cell Subset Phenotypes with Disease Stage and Prognosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only